SAN DIEGO --(BUSINESS WIRE)--Feb. 14, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration ( FDA ) has classified the t:slim X2™ insulin pump as the first in a new device category

SAN DIEGO --(BUSINESS WIRE)--Jan. 21, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2018 results after the financial markets close on Tuesday, February 26, 2019 .

SAN DIEGO --(BUSINESS WIRE)--Jan. 3, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Rebecca (Beckie) Robertson was appointed as an independent member of its board of directors.

SAN DIEGO --(BUSINESS WIRE)--Nov. 13, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Kim Blickenstaff , President and Chief Executive Officer and Leigh Vosseller , EVP and Chief Financial Officer, will present at

SAN DIEGO --(BUSINESS WIRE)--Nov. 12, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it has been named a top workplace in San Diego by The San Diego Union-Tribune and awarded a “Future Forward” 2018 Top Workplaces

SAN DIEGO --(BUSINESS WIRE)--Nov. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present at the following upcoming investor conferences: Stifel 2018 Healthcare Conference on Tuesday, November 13,

SAN DIEGO --(BUSINESS WIRE)--Nov. 1, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2018 . Third Quarter 2018 Results In comparing the third quarter of 2018 to

SAN DIEGO --(BUSINESS WIRE)--Oct. 17, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, plans to release its third quarter 2018 results after the financial markets close

SAN DIEGO --(BUSINESS WIRE)--Oct. 12, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has received a Heath Canada Medical Device License

Continued Domestic Demand and International Launch of the t:slim X2 Insulin Pump Drive Growth SAN DIEGO --(BUSINESS WIRE)--Sep. 25, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring

SAN DIEGO --(BUSINESS WIRE)--Sep. 12, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced it will host an Institutional Investor and Analyst Day from 8:30am

SAN DIEGO --(BUSINESS WIRE)--Aug. 29, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that Kim Blickenstaff , president and CEO, will present a company

SAN DIEGO --(BUSINESS WIRE)--Aug. 17, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2™ Insulin Pump with Basal-IQ™

SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has fully repaid its term loan made by Capital

Study Demonstrates Significant Reduction in Hypoglycemia without Rebound Hyperglycemia SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM)

SAN DIEGO --(BUSINESS WIRE)--Aug. 7, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), (“Tandem”) a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the closing of its previously announced underwritten public offering

SAN DIEGO --(BUSINESS WIRE)--Aug. 3, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem”), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of 3,508,770 shares of

SAN DIEGO --(BUSINESS WIRE)--Aug. 2, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem”), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has commenced a proposed underwritten public offering of its

SAN DIEGO --(BUSINESS WIRE)--Jul. 30, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pump available in the United States , today reported its financial results for the quarter ended June 30, 2018 .

SAN DIEGO --(BUSINESS WIRE)--Jul. 16, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its second quarter 2018 results after the financial markets close on Monday,